Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950162-05-000017
Filing Date
2005-01-05
Accepted
2005-01-05 13:28:00
Documents
1
Period of Report
2005-01-03

Document Format Files

Seq Description Document Type Size
1 sigmaform4-010505_ex.html 4  
1 sigmaform4-010505_ex.xml 4 5301
  Complete submission text file 0000950162-05-000017.txt   7265
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 00144 ROME ITALY
Business Address
SIGMA TAU FINANZIARIA SPA (Reporting) CIK: 0001092601 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-15070 | Film No.: 05511552